| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/21/2003 | US6509015 Human antibodies that bind human TNFa |
| 01/21/2003 | US6508984 Rapid robotic combinatorial production and screening of catalyst libraries |
| 01/21/2003 | US6508935 Of a membrane filter based on the molecular mass distribution curve of the rejected solute fraction of a feed solution when the feed is passed through the membrane |
| 01/21/2003 | US6508105 Apparatus and method for measuring the characteristics of an oilfield fluid or the like |
| 01/21/2003 | US6508100 System and method for resetting vehicle engine oil sensors |
| 01/21/2003 | US6508009 Gemstone measurement apparatus |
| 01/21/2003 | CA2453344A1 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | CA2328194C A system for cell-based screening |
| 01/21/2003 | CA2256686C Multicomponent analysis method including the determination of a statistical confidence interval |
| 01/21/2003 | CA2253965C Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood |
| 01/21/2003 | CA2204253C Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 01/21/2003 | CA2199824C Monitoring methods and devices for use therein |
| 01/21/2003 | CA2056312C Washing solution for solid-phase immunometric methods which contains stabilizers for the labeling system, and the use thereof |
| 01/21/2003 | CA2056062C Method and apparatus for quantitative evaluation of agglutination reactions |
| 01/18/2003 | CA2393382A1 Modular analytical system and connecting plug |
| 01/17/2003 | CA2407295A1 Transgenic non-human mammal |
| 01/17/2003 | CA2393895A1 Serological test for isav in fish |
| 01/16/2003 | WO2003005628A2 Generating, viewing, interpreting, and utilizing a quantitative database of metabolites |
| 01/16/2003 | WO2003005450A2 Nanoscale wires and related devices |
| 01/16/2003 | WO2003005301A1 In vitro method of evaluating the biological activity of compounds on a large scale in suitable physiological or pathological conditions |
| 01/16/2003 | WO2003005039A1 Method of preparing solution for quantification, quantification method using solution for quantification, instrument for preparing solution for quantification and method of using the same |
| 01/16/2003 | WO2003005038A1 Identification of modulators of neurotransmitter activity of xanthurenic acid |
| 01/16/2003 | WO2003005037A1 Method for separating and/or detecting and/or identifying and/or quantifying prion proteins |
| 01/16/2003 | WO2003005036A2 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | WO2003005035A1 Chp for use as marker for sepsis-type inflammatory diseases |
| 01/16/2003 | WO2003005033A2 Carcinoma-related peptides |
| 01/16/2003 | WO2003005032A2 Method for screening molecules which can bind to the gp120 protein of the immunodeficiency virus |
| 01/16/2003 | WO2003005031A1 Carrier particle latex for assay reagent and assay reagent |
| 01/16/2003 | WO2003005030A1 Two-photon absorbing dipyrrometheneboron difluoride dyes and their applications |
| 01/16/2003 | WO2003005029A2 Magnetic nanoparticles for bioseparation application and methods for producing same |
| 01/16/2003 | WO2003005028A1 Method for selecting bioactive agents by luminescence coupling and living cell system therefor |
| 01/16/2003 | WO2003005027A1 Protein chip for diagnosis allergy and detection method for allergen and antibody |
| 01/16/2003 | WO2003005026A2 Chemical capture reagent |
| 01/16/2003 | WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma |
| 01/16/2003 | WO2003005024A1 Use of disease-associated gene |
| 01/16/2003 | WO2003005023A2 Method for determining the interaction between keratinocytes and neurons |
| 01/16/2003 | WO2003005022A1 A method for solid state genome analysis |
| 01/16/2003 | WO2003005021A1 Method for integrated medical and sociological evaluation of public health |
| 01/16/2003 | WO2003005020A1 See through testing device |
| 01/16/2003 | WO2003005015A1 Glucose strip sensor and glucose measurement method using the glucose strip sensor |
| 01/16/2003 | WO2003005013A1 Filtration-based microarray chip |
| 01/16/2003 | WO2003005004A1 Method for determining the paper quality for halftone printing |
| 01/16/2003 | WO2003005001A1 Method and device for detecting chemical substance |
| 01/16/2003 | WO2003004995A2 High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation |
| 01/16/2003 | WO2003004993A2 Satterned composite membrane and stenciling method for the manufacture thereof |
| 01/16/2003 | WO2003004992A2 Mammalian sweet and amino acid heterodimeric taste receptors |
| 01/16/2003 | WO2003004990A2 Quantitative in vitro bone induction assay |
| 01/16/2003 | WO2003004706A1 Glucocorticoid-induced receptor and methods of use |
| 01/16/2003 | WO2003004700A1 Method and system for detecting inter-chromosomal imbalance by fluorescent in situ hybridization (fish) on interphase nuclei |
| 01/16/2003 | WO2003004699A2 Method for identifying nucleic acid molecules amplified in a polymerase chain reaction |
| 01/16/2003 | WO2003004698A2 Method for monitoring and modulating protein folding |
| 01/16/2003 | WO2003004697A2 Method for detecting mutagenic substances |
| 01/16/2003 | WO2003004695A1 Methods for identifying agents that modulate diacylglycerol kinase delta (dgk&) alktivity |
| 01/16/2003 | WO2003004694A1 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 01/16/2003 | WO2003004693A2 Methods and compositions for modulating adenosine triphosphate (atp) in cells and preventing cell injury or death via post-translational modifications to atp synthase |
| 01/16/2003 | WO2003004677A2 Methods for generating differential profiles by combining data obtained in separate measurements |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004650A2 Group b streptococcus antigens and corresponding dna fragments |
| 01/16/2003 | WO2003004645A1 Diagnosis and treatment of cancer involving the notch pathway |
| 01/16/2003 | WO2003004627A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | WO2003004623A2 Human secreted proteins |
| 01/16/2003 | WO2003004616A2 Dendritic cell isolation methods |
| 01/16/2003 | WO2003004613A2 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | WO2003004611A2 Human olfactory nucleotide-gated ion channels |
| 01/16/2003 | WO2003004608A2 Drug metabolizing enzymes |
| 01/16/2003 | WO2003004607A2 Aggrecanase molecules |
| 01/16/2003 | WO2003004605A2 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 01/16/2003 | WO2003004604A2 Phage displayed pdz domain ligands |
| 01/16/2003 | WO2003004601A2 New assays for preimplantation factor and preimplantation factor peptides |
| 01/16/2003 | WO2003004532A2 Q9ul33/q9nzz4 and q9h5p3 splice variants |
| 01/16/2003 | WO2003004531A2 Regulation of human somatostatin receptor-like protein |
| 01/16/2003 | WO2003004530A1 Regulation of human somatostatin receptor-like protein |
| 01/16/2003 | WO2003004520A2 Mycobacterial antigens expressed during latency |
| 01/16/2003 | WO2003004458A1 New compounds |
| 01/16/2003 | WO2003004279A1 Thermal printhead adjustment |
| 01/16/2003 | WO2003004057A1 Ephrin and eph receptor mediated immune modulation |
| 01/16/2003 | WO2003004050A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | WO2003004007A2 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) |
| 01/16/2003 | WO2003004006A2 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 01/16/2003 | WO2003003986A2 Parathyroid hormone antibodies and related methods |
| 01/16/2003 | WO2003003979A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | WO2003003906A2 Diagnostic and screening methods for bladder cancer |
| 01/16/2003 | WO2003003904A2 Coactivators in the diagnosis and treatment of breast cancer |
| 01/16/2003 | WO2003003824A1 Potential-dependent ca2+ channel a1b knockout non-human animal |
| 01/16/2003 | WO2003003810A2 Methods for detection and quantification of analytes in complex mixtures |
| 01/16/2003 | WO2002094194A3 Compositions and methods for inhibiting metastasis |
| 01/16/2003 | WO2002088715A3 Biopolymer marker having a molecular weight of 1465 daltons |
| 01/16/2003 | WO2002088711A3 Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons |
| 01/16/2003 | WO2002088178A3 Antigens of group b streptococcus and corresponding dna fragments |
| 01/16/2003 | WO2002088174A3 Biopolymer marker having a molecular weight of 1865 daltons |
| 01/16/2003 | WO2002086509A8 Method and means for detecting gluten-induced diseases |
| 01/16/2003 | WO2002082081A3 Suppression of androgen receptor transactivation through new pathways to ar and ar coactivators and repressors |
| 01/16/2003 | WO2002077023A3 A new essential downstream component of the wingless signalling pathway |
| 01/16/2003 | WO2002074438A3 Structural units that define fluidic functions |
| 01/16/2003 | WO2002059148A8 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/16/2003 | WO2002059147A3 Activatable cytolytic or drug delivery peptides and uses thereof |
| 01/16/2003 | WO2002057781A3 Methods of manufacturing reagent test strips |
| 01/16/2003 | WO2002056311A3 Optical disc analysis system including related methods for biological and medical imaging |
| 01/16/2003 | WO2002056010A3 Methods for the treatment of ibs |
| 01/16/2003 | WO2002056004A8 Thin film electrophoresis apparatus and method |